Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for HEPH: the economy's impact on HEPH's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: HOLLIS-EDEN PHAR -- HEPH 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS 3 $4 View Abstract
30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Hollis-Eden Pharmaceuticals, Inc. 42 $65 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Hollis-Eden Pharmaceuticals, Inc. Financial and Strategic Analysis Review 18 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for HEPH 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 12 new Laggards. 52 $20 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for HEPH: the economy's impact on HEPH's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: HOLLIS-EDEN PHAR -- HEPH 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS 3 $4 View Abstract
30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Hollis-Eden Pharmaceuticals, Inc. 42 $65 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Hollis-Eden Pharmaceuticals, Inc. Financial and Strategic Analysis Review 18 $300 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for HEPH 13 $25 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 12 new Laggards. 52 $20 View Abstract
Next 3

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.